OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Allergy and Clinical Immunology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
What molecular allergy teaches us about genetics and epidemiology of allergies	27
The use of environmental exposure chambers in studies related to ocular surface effects	26
The pathogenetic role of Th17 immune response in atopic dermatitis	22
Economic burden of drug-induced anaphylaxis: what can we do better?	20
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	20
Anaphylaxis due to antiallergic and antiasthmatic biologics	20
Is immunotherapy safe for treatment of severe asthma	20
New approaches in childhood asthma treatment	19
Consequences of severe asthma exacerbations	19
E-cigarettes and asthma in adolescents	19
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	19
Liver disease in primary antibody deficiencies	19
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	19
Atopic manifestations of inborn errors of immunity	18
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	18
Update on occupational allergy, including asthma, to soluble platinum salts	18
Mast cell conditions and drug allergy: when to suspect and how to manage	18
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	17
Real-world evidence of allergen immunotherapy	17
Editorial introductions	17
Editorial introductions	16
Perioperative anaphylaxis: when the allergological work-up goes negative	15
Ocular involvement in allergic drug reactions	15
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	15
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	15

Transition of care in inborn errors of immunity	14
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	14
Updates in diagnosis and management of paediatric mastocytosis	13
Editorial introductions	13
A review of food allergy-related costs with consideration to clinical and demographic factors	13
Editorial introductions	13
Clinical remission in severe asthma: lights and shadows on an ambitious goal	12
Updates in school-based asthma management	12
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	12
Management and treatment of perioperative hypersensitivity	12
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	12
Health disparities in allergic diseases	12
The complexity in DNA methylation analysis of allergic diseases	11
Food-labeling issues for severe food-allergic consumers	11
Role of the ocular surface microbiome in allergic eye diseases	10
Food allergy: new therapeutic options open deeper questions	10
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	10
Biomarkers in the diagnosis of mast cell activation	10
Editorial introductions	10
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	9
Precision allergy molecular diagnosis applications in food allergy	9
Precision medicine to personalize medicine in allergic airway disease	9
Interstitial lung diseases in inborn errors of immunity	9
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	9
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	9
Immunobiologicals and ocular surface disease	9
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	9
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	9
Strengthening the case for intralymphatic immunotherapy	9
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	9
Occupational respiratory allergy to reactive dyes	9
Editorial introductions	8
Adverse effects of anti-cancer biologics on the ocular surface	8
The role of macrolides in chronic rhinosinusitis and nasal polyps	8
Omalizumab is the Columbus egg for food allergies	8
MicroCrystalline Tyrosine-adsorbed immunotherapy	8
New causes of occupational allergic contact dermatitis	8
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	8
Editorial introductions	8
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	8
Endotypes of occupational asthma	8
Giant cell arteritis and innovative treatments	8
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	8
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	8
The risk of anaphylaxis on holidays	8
Clinical outcomes of AIT in the elderly population	7
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	7
The development of the DEFASE project	7
An update on patient reported outcomes in type 2 inflammation airway disease	7
Editorial introductions	7

Genetic landscape of atopic dermatitis	7
New evidence in food allergies treatment	7
Role of biologics in severe food allergy	7
Moderate asthma: burden, mechanisms and therapeutic perspectives	7
Ocular surface disorders: office procedures for the allergist/clinical immunologist	7
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis	7
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	7
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	7
Editorial: Pharmacotherapy and evidence based medicine	7
Editorial introductions	7
New insights into the mechanisms of aspirin-exacerbated respiratory disease	7
Perioperative anaphylaxis: updates on pathophysiology	6
Corneal complications of rheumatoid arthritis	6
Management of food allergy based on oral food challenge	6
Biologics to treat anaphylaxis	6
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	6
Editorial introductions	6
Biologics and severe asthma in children	6
Applying the new guidelines to asthma management in children	6
STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders	6
Diagnosis, management and therapeutic options for eosinophilic esophagitis	6
Editorial introductions	6
Anaphylaxis in elderly people	6
Biologicals in IgE-mediated food allergy	5
Anaphylaxis: glimpse into the future, attention to the present	5
Long-term outcome of occupational asthma with different etiology	5
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	5
Integrative therapeutics for ocular surface disorders	5
Advances in gene therapy for inborn errors of immunity	5
Editorial introductions	5
The evolution of cyclosporine treatments for treatment of ocular surface diseases	5
Chronic urticaria: not only after COVID-19 vaccination	5
Regular consumption following early introduction of allergenic foods and aggressive treatment of eczema are necessary for preventing the development of food allergy in children	5